SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007256
Filing Date
2021-05-14
Accepted
2021-05-14 16:02:07
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210331x10q.htm   iXBRL 10-Q 1518186
2 EX-31.1 tmb-20210331xex31d1.htm EX-31.1 16597
3 EX-31.2 tmb-20210331xex31d2.htm EX-31.2 13530
4 EX-32.1 tmb-20210331xex32d1.htm EX-32.1 7660
5 EX-32.2 tmb-20210331xex32d2.htm EX-32.2 7038
  Complete submission text file 0001558370-21-007256.txt   5389264

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210331.xsd EX-101.SCH 41028
7 EX-101.CAL tmb-20210331_cal.xml EX-101.CAL 37844
8 EX-101.DEF tmb-20210331_def.xml EX-101.DEF 204876
9 EX-101.LAB tmb-20210331_lab.xml EX-101.LAB 293707
10 EX-101.PRE tmb-20210331_pre.xml EX-101.PRE 318465
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210331x10q_htm.xml XML 762608
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 21924417
SIC: 2834 Pharmaceutical Preparations